Literature DB >> 6414186

Improvement of plasma quality as raw material for factor VIII:C concentrates. Storage of whole blood and plasma and interindividual plasma levels of fibrinopeptide A.

G Carlebjörk, M Blombäck, O Akerblom.   

Abstract

Blood collected into different anticoagulants was stored in small tubes at +4 degrees C for up to 26 h. Seven blood coagulation analyses were performed under standardized conditions. High yield and stability of factor VIII:C were found for ACD and CPD-adenine. No changes could be found in the other six parameters tested. Whole blood in blood bags could be stored for 2-4 h at +4 degrees C with maximal yield of F VIII:C, with blood stored overnight the recovery was 65%. In plasma F VIII:C was stable for at least 2 h at room temperature. F VIIIR:Ag and F VIIIR:RCoF were stable in both whole blood and plasma. No activation by plasmin as measured by B beta 15-42 could be demonstrated. The initial FPA levels, reflecting thrombin activation, in the donated blood differed individually and in some blood bags very high concentrations were found. The levels of FPA were not correlated to the time for collection of a bag of blood.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414186     DOI: 10.1111/j.1423-0410.1983.tb01909.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran.

Authors:  Azadeh Omidkhoda; Mohammad Reza Tabatabaei; Kamran Atarodi; Kamran Karimi; Abbas Rahimi Froushani; Ali Akbar Pourfathollah
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

2.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

3.  Factor VIII and fibrinogen recovery in plasma after Theraflex methylene blue-treatment: effect of plasma source and treatment time.

Authors:  André Rapaille; Stefan Reichenberg; Tome Najdovski; Nicolas Cellier; Nicolas de Valensart; Véronique Deneys
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

4.  Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group.

Authors:  Fay Betsou; Alexandre Bulla; Sang Yun Cho; Judith Clements; Rodrigo Chuaqui; Domenico Coppola; Yvonne De Souza; Annemieke De Wilde; William Grizzle; Fiorella Guadagni; Elaine Gunter; Stacey Heil; Verity Hodgkinson; Joseph Kessler; Michael Kiehntopf; Hee Sung Kim; Iren Koppandi; Katheryn Shea; Rajeev Singh; Marc Sobel; Stella Somiari; Demetri Spyropoulos; Mars Stone; Gunnel Tybring; Klara Valyi-Nagy; Gert Van den Eynden; Lalita Wadhwa
Journal:  Biopreserv Biobank       Date:  2016-04-05       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.